Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

Research Performance Progress Report Required for Non-SNAP Progress Reports Beginning October 17, 2014

The National Institutes of Health (NIH) currently requires use of the federal wide progress reporting format — known as the RPPR (Research Performance Progress Report) — to submit progress reports for Streamlined Non-competing Award Process (SNAP), fellowship, and multi-year funded awards. In April NIH opened the RPPR for use for all Type 5 Non-SNAP progress reports in anticipation of an October 2014 requirement for RPPR use.

Now, it’s official — all type 5 non-SNAP progress reports submitted on or after October 17, 2014 need to be submitted through the RPPR module of eRA Commons. This announcement is part of NIH’s ongoing transition to requiring the use of the federal government-wide RPPR format for all progress reporting.

NIH’s website on the RPPR provides information on the why, what, and when of the RPPR, with a handy table that lets you know for which types of grants the RPPR is now required, and for which it is still optional.

See more at: http://nexus.od.nih.gov/all/2014/06/30/rppr-required-for-non-snap-progress-reports-beginning-october-17-2014/?utm_source=nexus&utm_medium=email&utm_content=nihupdate&utm_campaign=jun13#sthash.8GUpbgGT.dpuf .

 
National Multiple Sclerosis Society

The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.

The prize is administered by the National Multiple Sclerosis Society. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research

For more information and guidelines , visit the Society’s website.

 
Josiah Macy Jr. Foundation

The Macy Foundation is pleased to invite applications for the fifth class of Macy Faculty Scholars.

The Macy Faculty Scholars program is designed to identify and nurture the careers of promising educational innovators in medicine and nursing. With support from the Macy Foundation, scholars will implement new educational innovations at their home institutions and participate in career development activities.

Chosen scholars will receive:
• Salary support of up to $100,000 per year for two years
• At least 50% protected time for two years to pursue educational projects
• Active mentorship by a senior faculty member at their institution
• Access to the program’s national advisory committee
• Opportunities to participate in Macy conferences and other national meetings

For more information and guidelines, visit the Macy Foundation website.

 
The Ohio Clinical Trial Collaborative (OCTC)

The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.

The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.

Review the OCTC working website at: http://ohioclintrials.org.

Contact Joe Peter at 216-702-5314 for more information.

 
J.M. Kaplan Fund

Through its Furthermore program, the J.M. Kaplan Fund supports nonfiction books about the urban experience; natural and historic resources; art, architecture, and design; cultural history; and civil liberties and other public issues.

The program seeks work that appeals to an informed general audience; demonstrates evidence of high standards in editing, design, and production; promises a reasonable shelf life; might not otherwise achieve top quality or even come into being; and "represents a contribution without which we would be the poorer."

Individual grants range from $500 to approximately $15,000 and may be used to support writing, research, editing, design, indexing, photography, illustration, and/or printing and binding.

See the Furthermore website for complete application guidelines and program information.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.